FDA Approved: LENVIMA — Original Application (Eisai Inc.)

View source ↗

Summary

FDA approves LENVIMA (lenvatinib) in its original application for the treatment of differentiated thyroid carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

ORIG AP for LENVIMA (LENVATINIB)